Tag Archives: FDA

CHI Offering Free Webinar on FDA Draft Guidances

chi-logo-btn

The California Healthcare Institute will be hosting a free online discussion on Tuesday, October 25, 2011 that addresses the FDA’s recently released draft guidance documents: Draft Guidance for Industry and Food and Drug Administration Staff – Factors to Consider when Making Benefit-Risk Determinations in Medical Device Premarket Review (Aug. 15, 2011) Draft Guidance for Industry, Clinical Investigators, and Food and Drug Administration Staff – Design Considerations for Pivotal Clinical Investigations for Medical Devices (Aug. 15, 2011) Date: October Read More >

Public Policy  |  2 Comments  |  Email This Post
Tags: , ,

Medical Innovation at Risk

Scientists

The National Venture Capital Association’s MedIC Coalition recently released a report showing U.S. venture capitalists are decreasing their investments in biopharmaceutical and medical device companies, reducing their concentration in prevalent disease areas and shifting investments towards Europe and Asia. The report, Vital Signs: The Threat to Investment in U.S. Medical Innovation and the Imperative of FDA Reform, strongly indicates that America’s medical innovation economy is in grave danger of losing its primary source of funding, Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Boosting Investment in Biotech

Biofuel Research

The President’s Council on Jobs and Competitiveness issued an interim report with suggestions to increase job creation and growth in the U.S., as well as plans for encouraging investment in the industry. Of particular interest to the biotech industry, the report offers suggestions for streamlining the FDA approval process. The report also outlines ideas for eliminating capital gains on investments of $25 million or less that are held for at least five years and recommends Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Is Animal Biotechnology Progressing?

David Edwards

By David Edwards, PhD Director, Animal Biotechnology, BIO One year ago, I was pleased to testify before the U.S. Food and Drug Administration’s (FDA) Veterinary Medicine Advisory Committee (VMAC).  The FDA convened its VMAC meetings on September 19-21, 2010 to discuss an application for a genetically engineered (GE) salmon. Developed by Massachusetts-based AquaBounty Technologies, a BIO member, the AquAdvantage salmon has been genetically engineered to grow year-round.  Conventional salmon only grow in warmer months.  This Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

How to grow the economy and feed the world

4890200485_ce7b17cef7

By Barbara Wells, President and CEO, ArborGen Chair, BIO Food and Agriculture Section Governing Board For the past two decades, the United States has led the world in crop biotechnology innovation. Under this leadership, American growers have produced most of the world’s food, fiber and energy, while the U.S. agricultural sector experienced sustained economic growth and a positive trade balance. But an increasingly complicated regulatory system and threats of litigation from opponents of technology have Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , ,